Dr Reddy’s share prices dropped today as brokerages cut targets due to weak US and India performance. Explore the financial outlook now!
Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback